What You Ought to Know:
– Viome Life Sciences, a mission-driven digital well being firm, introduced further $67M in funding towards its Collection C spherical.
– Led by Daring Capital Group, the $67M increase brings the corporate’s whole funding to over $150M and will likely be used to help the event of its at-home assessments that leverage precision diet to enhance well being and enhance longevity by addressing the epidemic of power ailments, cancers, and growing older.
– Viome will increase its proprietary mRNA sequencing expertise and AI-powered platform that was awarded FDA Breakthrough Gadget Designation standing, to debut a set of latest wellness and diagnostic assessments particularly concentrating on the oral microbiome which has a powerful connection to systemic ailments. This may embrace hard-to-detect cancers and GI problems reminiscent of IBD.
– The funding announcement comes off the heels of Viome’s first CancerDetect™ check, a revolutionary early diagnostic instrument that may detect not simply stage 1 however early biomarkers related to oral and throat most cancers with unprecedented charges of 95% specificity and 90% sensitivity.